- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07564583
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
The goal of this study is to finalize a version of the Safety Planning Intervention suitable for 6-12-year-old children. This intervention provides individuals with strategies to reduce the risk of suicidal behavior.
The main questions it aims to answer are:
- Does the intervention appear clear and acceptable to the children and caregivers?
- Does the intervention work to reduce suicidal behavior? Researchers will compare the group that received the intervention to a group that did not receive it, and to a group that received it and reported daily on its use.
Participants will:
- Children and parents will respond to questions in an interview and through self-reports in an in-person meeting
- Children and parents will receive the intervention (those in the intervention groups)
- Parents will report daily for one month (only those in the intervention + reporting group)
- Children and parents will meet with the study team through a video call at 1 and 3 months from the first meeting for an interview.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Children Hospital of Philadelphia
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Children aged 6-12
- Active suicidal ideation or a suicidal behavior in the last month
- The child and their caregiver are English speakers
- The child will be in an outpatient treatment at CHOP at the time of enrollment and baseline procedures
Exclusion Criteria:
- Child received a diagnosis of a psychotic disorder or intellectual disability
- Child is suffering from active mania
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Tratamiento habitual (TAU)
|
|
|
Experimental: Child-safety planning intervention (C-SPI) + TAU
Child - Safety Planning Intervention |
The Child Safety Planning Intervention (C-SPI) provides psychoeducation to children and caregivers about emotions, thoughts, and behaviors, emphasizing how these interact and change over time. Suicidal thoughts are framed as temporary reactions to triggers that can be recognized and managed. The intervention reviews a recent suicidal crisis to identify triggers, thoughts, feelings, and behaviors, which are then used to help the child recognize warning signs in the future. These signs are organized into levels (green, yellow, red), each linked to specific action steps.
Otros nombres:
|
|
Otro: C-SPI + TAU + ecological momentary assessment
Child - Safety Planning Intervention and daily reporting |
The Child Safety Planning Intervention (C-SPI) provides psychoeducation to children and caregivers about emotions, thoughts, and behaviors, emphasizing how these interact and change over time. Suicidal thoughts are framed as temporary reactions to triggers that can be recognized and managed. The intervention reviews a recent suicidal crisis to identify triggers, thoughts, feelings, and behaviors, which are then used to help the child recognize warning signs in the future. These signs are organized into levels (green, yellow, red), each linked to specific action steps.
Otros nombres:
C-SPI and daily, self-reported use of C-SPI
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Feasibility and acceptability of the C-SPI
Periodo de tiempo: At baseline (following the intervention), and at 1 and 3 months follow-ups
|
Whether intervention is clear and perceived as helpful on a scale of 1-5 (higher score indicates better perception of helpfulness) |
At baseline (following the intervention), and at 1 and 3 months follow-ups
|
|
Utilization of the C-SPI
Periodo de tiempo: Daily for a month (through EMA), and at 1 and 3 month follow-ups
|
Whether the C-SPI was used or not (0 or 1) |
Daily for a month (through EMA), and at 1 and 3 month follow-ups
|
|
Suicidal behavior
Periodo de tiempo: 1 and 3 months
|
Whether suicidal behavior was present and how many times (count variable beginning with zero; higher score indicating worse outcome) |
1 and 3 months
|
|
Suicidal ideation severity
Periodo de tiempo: 1 and 3 months
|
On a scale of 0-5 with higher score indicating worse outcome |
1 and 3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mental health treatment engagement/service utilization
Periodo de tiempo: 1 and 3 months
|
Number of contact with mental health providers (count variable beginning with zero; higher score indicating better outcome) |
1 and 3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Liat Itzhaky, PhD, Columbia University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- AAAV3403
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .